UNSPSC 51422364: Prednisolone sodium phosphate

This classification denotes a therapeutic glucocorticoid with the molecular formula C21H27O8P.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IV021NXA9J, chemically known as 3,20-dioxo-11beta,17alpha,21-trihydroxy-1,4-pregnadiene but more generally known as prednisolone sodium phosphate, which bears US NIH Compound Identifier 5755. European Medicines Agency schedules Prednisolone sodium phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04018MIG.

UNSPSC 51422364 Prednisolone sodium phosphate is a Commodity code tracking a specific pharmaceutical product, yet the recent state and local opportunity record posted under this code describes procurement of naloxone and drug deactivation systems—a mismatch indicating minimal relevant activity in the code's actual scope. The single identified opportunity does not align with prednisolone sodium phosphate acquisition, suggesting the code sees little or no current state and local procurement demand for this corticosteroid medication.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and a response deadline of July 26, 2023. This record reflects public health commodity procurement but falls outside the prednisolone sodium phosphate category. Without additional recent opportunities specifically requesting this pharmaceutical product, the code does not demonstrate current or near-term state and local market demand.